Hematometra complicating hormone replacement therapy after radiation for cervical carcinoma.
Hematometra developed in a patient receiving sequential estrogen-progestogen hormone replacement therapy following radiation for cervical carcinoma. Diagnosis, treatment and therapeutic recommendations are discussed.
Sauer
M V
MV
Department of Obstetrics and Gynecology, University of Southern California, Los Angeles.
Tomlinson
M
M
Rich
W
W
D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy*; D004359:Drug Therapy, Combination; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects*; D005260:Female; D006409:Hematometra / Q000139:chemically induced*; D006801:Humans; D008525:Medroxyprogesterone / Q000009:adverse effects*; D008875:Middle Aged; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*
D004966:Estrogens, Conjugated (USP); D008525:Medroxyprogesterone